99 results
8-K
CHRS
Coherus Biosciences Inc
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
in the healthcare sector.
As a non-employee director, Ms. Erbez will receive compensation in accordance with the Company’s non-employee director compensation
8-K
CHRS
Coherus Biosciences Inc
9 Jan 24
Results of Operations and Financial Condition
9:41pm
revenue for the fiscal year ended December 31, 2023 in a public webcast presentation at the 42nd Annual J.P. Morgan Healthcare Conference. A copy
8-K
EX-99.1
vuo9zm hmsw
27 Oct 23
Regulation FD Disclosure
4:19pm
424B3
bieqzl ldyqn
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
jv6r3
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
p43wjp
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
7lu939
16 Jun 23
Business combination disclosure
5:11pm
425
zynxp4ja1
16 Jun 23
Business combination disclosure
8:08am
425
ehowdi8yl28484
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
gbxmgucb
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
mos8 sdbl8ob3ev60rp
18 May 23
Other Events
5:02pm